A Two-arm, Open-label, Single-sequence, Multiple Oral Dosings, Cross-over Design Clinical Trial to Evaluate the Safety and Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers
Latest Information Update: 10 Sep 2021
At a glance
- Drugs Dapagliflozin (Primary) ; Olmesartan medoxomil (Primary)
- Indications Diabetes mellitus; Hypertension
- Focus Pharmacokinetics
- Sponsors Autotelic Bio
Most Recent Events
- 18 Aug 2021 Status changed from active, no longer recruiting to completed.
- 29 Apr 2021 New trial record